Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 47

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?

Ornoy, Asher, Weinstein-Fudim, Liza, Ergaz, Zivanit · 2019 · International Journal of Molecular Sciences

Abstract

Since the first animal model of valproic acid (VPA) induced autistic-like behavior, many genetic and non-genetic experimental animal models for Autism Spectrum Disorder (ASD) have been described. The more common non-genetic animal models induce ASD in rats and mice by infection/inflammation or the prenatal or early postnatal administration of VPA. Through the establishment of these models, attempts have been made to ameliorate or even prevent ASD-like symptoms. Some of the genetic models have been successfully treated by genetic manipulations or the manipulation of neurotransmission. Different antioxidants have been used (i.e., astaxanthin, green tea, piperine) to reduce brain oxidative stress in VPA-induced ASD models. Agents affecting brain neurotransmitters (donepezil, agmatine, agomelatine, memantine, oxytocin) also successfully reduced ASD-like symptoms. However, complete prevention of the development of symptoms was achieved only rarely. In our recent study, we treated mouse offspring exposed on postnatal day four to VPA with S-adenosine methionine (SAM) for three days, and prevented ASD-like behavior, brain oxidative stress, and the changes in gene expression induced by VPA. In this review, we describe, in addition to our data, the existing literature on the prevention/amelioration of ASD-like symptoms. We also discuss the possible mechanisms underlying some of these phenomena. Finally, we describe some of the clinical trials in children with ASD that were carried out as a result of data from animal studies, especially those with polyunsaturated fatty acids (PUFAs).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms20051074

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Baio, 2018, Prevalence of Autism Spectrum Disorder among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014, MMWR Surveill. Summ., 67, 1, 10.15585/mmwr.ss6706a1 · DOI · Paper page
  2. Ergaz, 2016, Genetic and non-genetic animal models for autism spectrum disorders (ASD), Reprod. Toxicol., 64, 116, 10.1016/j.reprotox.2016.04.024 · DOI · Paper page
  3. Samaco, 2013, Female Mecp2(+/−) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies, Hum. Mol. Genet., 22, 96, 10.1093/hmg/dds406 · DOI · Paper page
  4. Meyza, 2017, The BTBR mouse model of idiopathic autism—Current view on mechanisms, Neurosci. Biobehav. Rev., 76, 99, 10.1016/j.neubiorev.2016.12.037 · DOI · Paper page
  5. Oddi, 2015, Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome, Neuropsychopharmacology, 40, 1113, 10.1038/npp.2014.291 · DOI
  6. Lee, 2015, Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?, Exp. Neurobiol., 24, 312, 10.5607/en.2015.24.4.312 · DOI
  7. Zhang, 2017, The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder, Adv. Anat. Embryol. Cell Biol., 224, 135, 10.1007/978-3-319-52498-6_8 · DOI
  8. Wagner, 2018, Oxytocin and Animal Models for Autism Spectrum Disorder, Curr. Top. Behav. Neurosci., 35, 213, 10.1007/7854_2017_15 · DOI
  9. Teng, 2016, Reversal of social deficits by subchronic oxytocin in two autism mouse models, Neuropharmacology, 105, 61, 10.1016/j.neuropharm.2015.12.025 · DOI
  10. Steinmetz, 2018, Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice, J. Neurosci., 38, 1015, 10.1523/JNEUROSCI.2010-17.2017 · DOI
  11. Yoshimura, 2017, Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model, Neuropharmacology, 126, 38, 10.1016/j.neuropharm.2017.08.029 · DOI
  12. Schwartzer, 2017, C57BL/6J bone marrow transplant increases sociability in BTBR T(+) Itpr3(tf)/J mice, Brain Behav. Immun., 59, 55, 10.1016/j.bbi.2016.05.019 · DOI
  13. Ornoy, A., Weinstein-Fudim, L., Tfilin, M., Ergaz, Z., Yanai, J., Szyf, M., and Turgeman, G. (2018). S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol. Teratol. · DOI · Paper page
  14. Carpentier, 2011, Placental TNF-alpha signaling in illness-induced complications of pregnancy, Am. J. Pathol., 178, 2802, 10.1016/j.ajpath.2011.02.042 · DOI
  15. Ohkawara, 2015, Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons, Brain Dev., 37, 88, 10.1016/j.braindev.2014.03.007 · DOI
  16. Xuan, I.C., and Hampson, D.R. (2014). Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS ONE, 9. · DOI
  17. Lancaster, 2007, Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus, Behav. Brain Res., 176, 141, 10.1016/j.bbr.2006.06.013 · DOI
  18. Kirsten, T.B., Casarin, R.C., Bernardi, M.M., and Felicio, L.F. (2018). Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS ONE, 13. · DOI
  19. Vuillermot, 2017, Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation, Mol. Autism, 8, 9, 10.1186/s13229-017-0125-0 · DOI
  20. Christianson, 1994, Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs, Dev. Med. Child Neurol., 36, 361, 10.1111/j.1469-8749.1994.tb11858.x · DOI · Paper page
  21. Williams, 2001, Fetal valproate syndrome and autism: Additional evidence of an association, Dev. Med. Child Neurol., 43, 202, 10.1111/j.1469-8749.2001.tb00188.x · DOI · Paper page
  22. Bromley, 2008, Autism spectrum disorders following in utero exposure to antiepileptic drugs, Neurology, 71, 1923, 10.1212/01.wnl.0000339399.64213.1a · DOI · Paper page
  23. Wagner, 2006, A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate, J. Autism Dev. Disord., 36, 779, 10.1007/s10803-006-0117-y · DOI · Paper page
  24. Rodier, 1997, Linking etiologies in humans and animal models: Studies of autism, Reprod. Toxicol., 11, 417, 10.1016/S0890-6238(97)80001-U · DOI · Paper page
  25. Banji, 2011, Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals, Brain Res., 1410, 141, 10.1016/j.brainres.2011.06.063 · DOI
  26. Rahman, 2015, Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism, Behav. Brain Res., 286, 112, 10.1016/j.bbr.2015.02.041 · DOI
  27. Pragnya, 2014, Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice, Behav. Brain Res., 270, 86, 10.1016/j.bbr.2014.04.045 · DOI
  28. Yadav, 2017, Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features, J. Physiol. Biochem., 73, 187, 10.1007/s13105-016-0532-2 · DOI
  29. Kumar, 2015, Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder, Neurochem. Int., 91, 34, 10.1016/j.neuint.2015.10.007 · DOI
  30. Kumar, 2016, Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats, Brain Res., 1630, 83, 10.1016/j.brainres.2015.10.052 · DOI
  31. Kumar, 2016, Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats, Brain Res. Bull., 124, 27, 10.1016/j.brainresbull.2016.03.013 · DOI
  32. Kim, J.W., Seung, H., Kwon, K.J., Ko, M.J., Lee, E.J., Oh, H.A., Choi, C.S., Kim, K.C., Gonzales, E.L., and You, J.S. (2014). Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism. PLoS ONE, 9. · DOI
  33. Hara, 2015, Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model, Behav. Brain Res., 289, 39, 10.1016/j.bbr.2015.04.022 · DOI
  34. Dai, 2018, Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism, Front. Cell. Neurosci., 12, 355, 10.3389/fncel.2018.00355 · DOI
  35. Ha, 2017, Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model, Behav. Brain Res., 317, 479, 10.1016/j.bbr.2016.10.004 · DOI
  36. Ornoy, 2018, Gender differences in the expression of nervous system genes in a mouse model of valproic acid-induced autism-like behavior is corrected by S-adenosyl methionine, Birth Defects Res., 11, 791
  37. Bjork, 2018, Association of Folic Acid Supplementation During Pregnancy with the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero, JAMA Neurol., 75, 160, 10.1001/jamaneurol.2017.3897 · DOI · Paper page
  38. Hara, 2016, Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism, Autism Res., 9, 926, 10.1002/aur.1596 · DOI
  39. Segal-Gavish, H., Karvat, G., Barak, N., Barzilay, R., Ganz, J., Edry, L., Aharony, I., Offen, D., and Kimchi, T. (2015). Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice. Autism Res. Off. J. Int. Soc. Autism Res. · DOI
  40. Seibenhener, M.L., and Wooten, M.C. (2015). Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp., e52434. · DOI · Paper page
  41. Basso, 1995, A sensitive and reliable locomotor rating scale for open field testing in rats, J. Neurotrauma, 12, 1, 10.1089/neu.1995.12.1 · DOI · Paper page
  42. Kuniishi, 2017, Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats, Neurosci. Res., 123, 27, 10.1016/j.neures.2017.04.012 · DOI
  43. Crawley, 2004, Designing mouse behavioral tasks relevant to autistic-like behaviors, Ment. Retard. Dev. Disabil. Res. Rev., 10, 248, 10.1002/mrdd.20039 · DOI · Paper page
  44. Kaidanovich-Beilin, O., Lipina, T., Vukobradovic, I., Roder, J., and Woodgett, J.R. (2011). Assessment of social interaction behaviors. J. Vis. Exp., 2473. · DOI · Paper page
  45. Komada, M., Takao, K., and Miyakawa, T. (2008). Elevated plus maze for mice. J. Vis. Exp., 1088. · DOI · Paper page
  46. Deacon, 2006, T-maze alternation in the rodent, Nat. Protoc., 1, 7, 10.1038/nprot.2006.2 · DOI · Paper page
  47. Hamisha, 2015, Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Ass25–35 administration, J. Mol. Neurosci., 55, 1006, 10.1007/s12031-014-0457-6 · DOI
  48. Guariglia, 2013, Water T-maze: A useful assay for determination of repetitive behaviors in mice, J. Neurosci. Methods, 220, 24, 10.1016/j.jneumeth.2013.08.019 · DOI
  49. Leger, 2013, Object recognition test in mice, Nat. Protoc., 8, 2531, 10.1038/nprot.2013.155 · DOI · Paper page
  50. Sestakova, 2013, Determination of motor activity and anxiety-related behaviour in rodents: Methodological aspects and role of nitric oxide, Interdiscip. Toxicol., 6, 126, 10.2478/intox-2013-0020 · DOI · Paper page
  51. Buccafusco, J.J. (2009). Anxiety-Related Behaviors in Mice. Methods of Behavior Analysis in Neuroscience, CRC Press/Taylor & Francis. [2nd ed.].
  52. Hamm, 1994, The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury, J. Neurotrauma, 11, 187, 10.1089/neu.1994.11.187 · DOI · Paper page
  53. Angoa-Perez, M., Kane, M.J., Briggs, D.I., Francescutti, D.M., and Kuhn, D.M. (2013). Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J. Vis. Exp., 50978. · doi:10.3791/50978-v · Paper page
  54. Morgese, M.G., and Trabace, L. (2016). Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids. Brain Sci., 6. · DOI
  55. Agostoni, C., Nobile, M., Ciappolino, V., Delvecchio, G., Tesei, A., Turolo, S., Crippa, A., Mazzocchi, A., Altamura, C.A., and Brambilla, P. (2017). The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD. Int. J. Mol. Sci., 18. · DOI
  56. Yui, 2012, Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: A double-blind, placebo-controlled, randomized trial, J. Clin. Psychopharmacol., 32, 200, 10.1097/JCP.0b013e3182485791 · DOI
  57. Bent, 2014, Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism, J. Am. Acad. Child Adolesc. Psychiatry, 53, 658, 10.1016/j.jaac.2014.01.018 · DOI
  58. Voigt, 2014, Dietary docosahexaenoic acid supplementation in children with autism, J. Pediatr. Gastroenterol. Nutr., 58, 715, 10.1097/MPG.0000000000000260 · DOI
  59. Horvath, 2017, omega-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis, J. Nutr., 147, 367, 10.3945/jn.116.242354 · DOI
  60. Cheng, 2017, Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: A meta-analysis of randomized controlled trials, Neuropsychiatr. Dis. Treat., 13, 2531, 10.2147/NDT.S147305 · DOI

Cited by

See all 47

Metadata

Authors
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-03-01
Volume
20
Issue
5
Pages
1074
ISSN
1422-0067
Cited by
47
References
21
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.